Hemoglobin Electrophoresis
HGB E
Description
"Hemoglobin Electrophoresis" test identifies different types of hemoglobin in your blood to detect genetic blood disorders. Doctors typically order this test to diagnose or monitor conditions like sickle cell anemia, thalassemia, or hemoglobin variants. A small blood sample is analyzed to separate and evaluate hemoglobin patterns. Abnormal findings may indicate inherited conditions or abnormal hemoglobin production. Results help clarify unexplained symptoms like fatigue or pallor. This test supports diagnosis, treatment planning, and long-term management of hemoglobin-related disorders.
Category
Blood Cells, Proteins
Procedure
Invasive
Sample Type
Blood – Whole Blood
Units
Percentage
Procedure Category
Blood Draw
Test Group
Hematology Group
Test Group Description
Hematology Group: Tests within this group focus on evaluating various aspects of blood health and function. These assessments provide insights into red blood cells, white blood cells, platelets, and other components of the blood.
Optimal Range
For All Individuals:
Conventional Unit: Type A: 95.00–98.00% | Type A2: 2.00–3.00% | Type F: 0.80–2.00% | Type S: 0.00% | Type C: 0.00%
SI Unit: Not Applicable
Normal Range
For All Individuals:
Conventional Unit: Type A: 95.00–98.00% | Type A2: 2.00–3.00% | Type F: 0.80–2.00% | Type S: 0.00% | Type C: 0.00%
SI Unit: Not Applicable
Results That Differ From The Norm (Direct and Indirect Causes)
Abnormal results may indicate:
Hemoglobin C disease (Inherited blood disorder similar to sickle cell disease)
Hemoglobin E disease (Inherited blood disorder affecting hemoglobin structure)
Hemoglobin Sβ-thalassemia (Genetic combination of sickle cell trait and thalassemia)
Polycythemia vera (Bone marrow disorder causing excess red blood cell production)
Sickle cell anemia (Inherited disorder causing abnormal hemoglobin)
Thalassemia (Inherited blood disorder affecting hemoglobin production)
Key Reasons For Testing
Diagnosis of Hemoglobinopathies: Identifies conditions like sickle cell disease, thalassemia, and hemoglobin variants by analyzing hemoglobin types.
Carrier Screening: Detects traits for disorders such as sickle cell or thalassemia for genetic counseling.
Newborn Screening: Ensures early detection of hemoglobinopathies, enabling prompt management.
Diagnostic Confirmation: Confirms suspected hemoglobin diso...
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Huisman TH, Carver MF, Efremov GD. A syllabus of human hemoglobin variants (1996). Augusta, GA: Sickle Cell Anemia Foundation.
[2] Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017;127(3):750-760.
[3] Clarke GM, Higgins TN. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. Clin Chem. 2000;46(8 Pt 2):1284-1290.
[4] Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassemias. Nat Rev Genet.2001;2(4):245-255.
[5] Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassaemia. Lancet. 2012;379(9813):373-383.
[6] Forget BG, Bunn HF. Classification of the disorders of hemoglobin. Cold Spring Harb Perspect Med.2013;3(2):a011858.
[7] Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101(3):791-800.
[8] Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005;129(4):465-481.
[9] Old JM. Screening and genetic diagnosis of hemoglobin disorders. Blood Rev. 2003;17(1):43-53.
[10] Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet J Rare Dis. 2010;5:13.
[11] Vichinsky E, MacKlin E, Waye JS, Lorey F, Lubin B. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics. 2005;116(6):e818-e825.
[12] Kazazian HH Jr. The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. Semin Hematol.1990;27(3):209-228.
[13] Das S, Chaudhuri K, Ghosh S. Modern techniques in hemoglobin electrophoresis: clinical implications in hemoglobinopathy diagnostics. Clin Biochem. 2018;57:15-21.
[14] Bain BJ. Hemoglobinopathy diagnosis: algorithms, automation, and clinical applications. Br J Haematol.2020;191(1):31-42.
[15] Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011;118(13):3479-3488.